MedPath

BHR Pharma, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

16

Active:11
Completed:2

Trial Phases

3 Phases

Phase 1:3
Phase 2:1
Phase 3:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 3
4 (50.0%)
Phase 1
3 (37.5%)
Phase 2
1 (12.5%)

Study of Progesterone in Treatment of Vasomotor Symptoms

Phase 3
Terminated
Conditions
Menopause Related Conditions
Interventions
Drug: Placebo oral capsule
First Posted Date
2017-06-28
Last Posted Date
2019-03-06
Lead Sponsor
BHR Pharma, LLC
Target Recruit Count
55
Registration Number
NCT03202186
Locations
🇩🇪

Fachärztin für Gynäkologie und Geburtshilfe, Bernburg, Germany

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

Phase 3
Terminated
Conditions
Mammographic Breast Density
Interventions
First Posted Date
2017-06-27
Last Posted Date
2022-07-26
Lead Sponsor
BHR Pharma, LLC
Target Recruit Count
223
Registration Number
NCT03199963
Locations
🇺🇸

Mesa Obstetricians and Gynecologists/Cactus Clinical Research, Mesa, Arizona, United States

🇺🇸

Visions Clinical Research, Tucson, Arizona, United States

🇺🇸

United Clinical Research, Beverly Hills, California, United States

and more 16 locations

Maintaining Suppression of Testosterone With Transdermal Estradiol Gel

Phase 2
Terminated
Conditions
Cancer of the Prostate
Interventions
First Posted Date
2015-01-28
Last Posted Date
2022-03-31
Lead Sponsor
BHR Pharma, LLC
Target Recruit Count
34
Registration Number
NCT02349386
Locations
🇺🇸

Urological Associates of Southern Arizona, Tucson, Arizona, United States

🇺🇸

South Florida Medical Research, Aventura, Florida, United States

🇺🇸

Advanced Urology Institute, Daytona Beach, Florida, United States

and more 8 locations

Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury

Phase 3
Completed
Conditions
Brain Injuries
Interventions
Drug: Lipid emulsion without progesterone
First Posted Date
2010-06-14
Last Posted Date
2024-10-02
Lead Sponsor
BHR Pharma, LLC
Target Recruit Count
1195
Registration Number
NCT01143064
Locations
🇺🇸

University of South Alabama Medical Center, Mobile, Alabama, United States

🇺🇸

LAC+USC Medical Center, Los Angeles, California, United States

🇺🇸

University of California San Diego Medical Center, San Diego, California, United States

and more 153 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath